Cat. No.: DAB-0011970
Product Information | |
---|---|
Clonality | Monoclonal |
Isotype | IgG1 |
Host Species | Mouse |
Reactivity | Human, Monkey |
Applications | WB, IP, IF |
Product Description | Monoclonal antibody is produced by immunizing animals with a recombinant human DLAT protein. |
Format | Liquid |
Purity | Affinity purity |
Target Information | |
---|---|
Target Name | DLAT |
UniProt No. | P10515 |
Gene ID | 1737 |
Gene Description | Dihydrolipoamide acetyltransferase transfers an acetyl group from pyruvate to CoA to synthesize acetyl-CoA. This protein, also known as the E2 subunit of the pyruvate dehydrogenase complex, has been implicated in the literature as the primary autoantigen in primary biliary cirrhosis. Antimitochondrial antibodies are likely formed when DLAT is exposed to the immune system in apoptotic cells of the bile duct. Research studies have shown that in some cases, cosmetics, NSAIDs, chewing gum, acetaminophen, and other compounds could trigger exposure of DLAT in sensitive individuals. The presence of AMAs is often detectable before disease diagnosis. Research studies have also shown that activation of the Toll-like receptor-3 pathway is involved in the progression from a subclinical to clinical state. |
Shipping & Storage | |
---|---|
Shipping | Shipped at 4 °C. |
Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.